학술논문
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
Document Type
Article
Author
Source
In: Targeted Oncology . (Targeted Oncology, May 2023, 18(3):391-402)
Subject
Language
English
ISSN
1776260X
17762596
17762596